🇺🇸 FDA
Patent

US 10246464

Thienopyrimidine and thienopyridine compounds and methods of use thereof

granted A61PA61P35/04

Quick answer

US patent 10246464 (Thienopyrimidine and thienopyridine compounds and methods of use thereof) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/04